Madeleine E. Harvey

This paper develops a targeted nanotherapeutic, FA-2DG-D-Niclo, which delivers niclosamide to FRβ-expressing macrophages, reducing endometriosis lesions and hyperalgesia in mice.

This study shows that repeated endometriosis lesion inductions in mice increase neuroinflammation and central sensitization, leading to chronic pelvic pain.

This study shows high-fat diets worsen endometriosis-related abdominal pain by increasing peritoneal inflammation and pain mediators.